Minakem is a fully integrated development partner and commercial manufacturer for pharmaceutical companies


  • Custom development (process development and optimization)
  • Custom manufacturing
  • API manufacturing (Innovators, Generics and Highly Potent)
  • Production of key intermediates and building blocks

All development and manufacturing activities are supported by highly skilled R&D technical centres,  strong and state-of-the-art analytical services including solid form and QbD laboratories.

MINAKEM’s talented team also ensures high-quality services in Quality Assurance, Regulatory Affairs, Safety, Health and Environment (SHE).

Minakem is a technology-driven company with expertise in complex multi-step synthesis, pressure chemistry, chiral synthesis, halogenation chemistry, steroid chemistry and “prazole” chemistry…

Minakem has operations in 3 different development and manufacturing sites, which are all approved by the U.S. FDA and local health agencies :

  • Dunkirk, France – former AstraZeneca “prazoles” and budesonide production site
  • Beuvry-la-Forêt, France
  • Louvain-la-Neuve, Belgium – former Ajinomoto-Omnichem site, specialized in vinca alkaloids synthesis

Strong synergies within MINAKEM offer customers the flexibility, responsiveness, and cost-effectiveness paired with the strong technical know-how to create significant added value within our customers’ supply chains.

Minakem is an affiliate of the MINAFIN Group and as such has access to all technologies, resources, and capabilities to respond to its client’s needs, especially with Minascent technologies (Leuna, Germany), and Pennakem (Memphis, TN, USA).

MINAFING Group Mission – Comex Members comment on the Group’s revised mission